# Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate Efficacy of CMS008618 for Common Cold

> **NCT03794804** · NA · COMPLETED · sponsor: **Enzymatica AB** · enrollment: 701 (actual)

## Conditions studied

- Common Cold

## Interventions

- **DEVICE:** ColdZyme
- **DEVICE:** ColdZyme Placebo

## Key facts

- **NCT ID:** NCT03794804
- **Lead sponsor:** Enzymatica AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-28
- **Primary completion:** 2019-06-26
- **Final completion:** 2019-06-26
- **Target enrollment:** 701 (ACTUAL)
- **Last updated:** 2019-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03794804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03794804, "Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate Efficacy of CMS008618 for Common Cold". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03794804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*